Evidence map›Paper›PMID 30968961›Full record

ArticleInternational journal of cancer2020

Mediation analysis of the alcohol-postmenopausal breast cancer relationship by sex hormones in the EPIC cohort.

Nada Assi, Sabina Rinaldi, Vivian Viallon, S Ghazaleh Dashti, Laure Dossus, Agnès Fournier, Iris Cervenka, Marina Kvaskoff, Renée Turzanski-Fortner, Manuela Bergmann and 28 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in International journal of cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 24 citations in OpenAlex.

  1. Linking Physical Activity to Breast Cancer via Sex Steroid Hormones, Part 2: The Effect of Sex Steroid Hormones on Breast Cancer Risk.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2022
    Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Identifying Metabolomic Mediators of the Physical Activity and Colorectal Cancer Relationship.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Alcohol and breast cancer.Pharmacological reports : PR · 2023
    Review
  11. Review
  12. Review
  13. Alcohol's Effects on Breast Cancer in Women.Alcohol research : current reviews · 2020
    Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors at 20 institutions in 11 countries.

Nada AssiNutritional Methodology and Biostatistics Group, International Agency for Research on Cancer (IARC), Lyon, France.ORCID 0000-0002-0629-3989
Sabina RinaldiBiomarkers Group, International Agency for Research on Cancer (IARC), Lyon, France.ORCID 0000-0002-6846-1204
Vivian ViallonNutritional Methodology and Biostatistics Group, International Agency for Research on Cancer (IARC), Lyon, France.
S Ghazaleh DashtiNutritional Methodology and Biostatistics Group, International Agency for Research on Cancer (IARC), Lyon, France.ORCID 0000-0002-1399-7220
Laure DossusNutritional Methodology and Biostatistics Group, International Agency for Research on Cancer (IARC), Lyon, France.
Agnès FournierCESP, Fac. de Médecine, Univ. Paris-Sud, Fac. de Médecine, UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.
Iris CervenkaCESP, Fac. de Médecine, Univ. Paris-Sud, Fac. de Médecine, UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.
Marina KvaskoffCESP, Fac. de Médecine, Univ. Paris-Sud, Fac. de Médecine, UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.ORCID 0000-0002-4557-3772
Renée Turzanski-FortnerDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Manuela BergmannDepartment of Epidemiology, German Institute of Human Nutrition, Nuthetal, Germany.
Heiner BoeingDepartment of Epidemiology, German Institute of Human Nutrition, Nuthetal, Germany.
Salvatore PanicoDipartimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy.
Fulvio RicceriDepartment of Clinical and Biological Sciences, University of Turin, Italy.ORCID 0000-0001-8749-9737
Domenico PalliCancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network - ISPRO, Florence, Italy.
Rosario TuminoCancer Registry and Histopathology Department, "Civic - M.P.Arezzo" Hospital, Ragusa, Italy.
Sara GrioniEpidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
María José Sánchez PérezCIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
María-Dolores ChirlaqueCIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Catalina BonetUnit of Nutrition and Cancer, Cancer Epidemiology Research Program, Institut Català d'Oncologia, L'Hospitalet de Llobregat, Spain.
Aurelio Barricarte GurreaCIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Pilar Amiano EtxezarretaCIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Susana MerinoPublic Health Directorate, Asturias, Spain.
H Bas Bueno de MesquitaDepartment of Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Carla H van GilsJulius Center for Health Sciences and Primary Care, Cancer Epidemiology University Medical Center, Utrecht, The Netherlands.
Charlotte Onland-MoretJulius Center for Health Sciences and Primary Care, Cancer Epidemiology University Medical Center, Utrecht, The Netherlands.
Anne TjønnelandDanish Cancer Society Research Center, Copenhagen, Denmark.
Kim OvervadThe Department of Epidemiology, School of Public Health, Aarhus University, Aarhus, Denmark.
Antonia TrichopoulouHellenic Health Foundation, Athens, Greece.
Georgia MartimianakiHellenic Health Foundation, Athens, Greece.
Anna KarakatsaniHellenic Health Foundation, Athens, Greece.
Tim KeyCancer Epidemiology Unit, University of Oxford, Oxford, United Kingdom.
Sofia ChristakoudiDepartment of Epidemiology and Biostatistics, MRC-HPA Centre for Environment and Health, School of Public Health, Imperial College London, London, United Kingdom.
Merete Ellingjord-DaleDepartment of Epidemiology and Biostatistics, MRC-HPA Centre for Environment and Health, School of Public Health, Imperial College London, London, United Kingdom.
Kostas TsilidisDepartment of Epidemiology and Biostatistics, MRC-HPA Centre for Environment and Health, School of Public Health, Imperial College London, London, United Kingdom.ORCID 0000-0002-8452-8472
Elio RiboliDepartment of Epidemiology and Biostatistics, MRC-HPA Centre for Environment and Health, School of Public Health, Imperial College London, London, United Kingdom.
Rudolf KaaksDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Marc J GunterNutritional Epidemiology Group, International Agency for Research on Cancer (IARC), Lyon, France.
Pietro FerrariNutritional Methodology and Biostatistics Group, International Agency for Research on Cancer (IARC), Lyon, France.
Centre international de recherche sur le cancer · FRInserm · FRUniversity Medical Center Utrecht · NLGerman Cancer Research Center · DEGerman Institute of Human Nutrition · DEHellenic Health Foundation · GRImperial College London · GBAarhus University · DKAzienda Usl 8 Arezzo · ITBiogipuzkoa Health Research Institute · ESFederico II University Hospital · ITFondazione IRCCS Istituto Nazionale dei Tumori · ITGobierno del Principado de Asturias · ESInstitut Català d'Oncologia · ESInstituto de Salud Pública de Navarra · ESInstituto Murciano de Investigación Biosanitaria · ESKing's College London · GBNational and Kapodistrian University of Athens · GRPiedmont Reference Center for Epidemiology and Cancer Prevention · ITRegional Health · US

Funding

Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3U01CA098216 · NCI · INTERNATIONAL AGENCY FOR RES ON CANCER · PI RIBOLI, ELIO · 2003 to 2011
$7.4M
Cancer Research UK 14136Cancer Research UK C570/A16491Cancer Research UK C8221/A19170Medical Research Council 1000143Medical Research Council G0401527Medical Research Council G1000143Medical Research Council MR/M012190/1Medical Research Council MR/N003284/1NCI NIH HHS 1U01CA98216-01NCI NIH HHS U01 CA098216World Health Organization 001
6 · The paper itself

Abstract

Alcohol consumption is associated with higher risk of breast cancer (BC); however, the biological mechanisms underlying this association are not fully elucidated, particularly the extent to which this relationship is mediated by sex hormone levels. Circulating concentrations of estradiol, testosterone, their free fractions and sex-hormone binding globulin (SHBG), were examined in 430 incident BC cases and 645 matched controls among alcohol-consuming postmenopausal women nested within the European Prospective Investigation into Cancer and Nutrition. Mediation analysis was applied to assess whether individual hormone levels mediated the relationship between alcohol intake and BC risk. An alcohol-related hormonal signature, obtained by partial least square (PLS) regression, was evaluated as a potential mediator. Total (TE), natural direct and natural indirect effects (NIE) were estimated. Alcohol intake was positively associated with overall BC risk and specifically with estrogen receptor-positive tumors with respectively TE = 1.17(95%CI: 1.01,1.35) and 1.36(1.08,1.70) for a 1-standard deviation (1-SD) increase of intake. There was no evidence of mediation by sex steroids or SHBG separately except for a weak indirect effect through free estradiol where NIE = 1.03(1.00,1.06). However, an alcohol-related hormonal signature negatively associated with SHBG and positively with estradiol and testosterone was associated with BC risk (odds ratio [OR] = 1.25 [1.07,1.47]) for a 1-SD higher PLS score, and had a statistically significant NIE accounting for a mediated proportion of 24%. There was limited evidence of mediation of the alcohol-BC association by individual sex hormones. However, a hormonal signature, reflecting lower levels of SHBG and higher levels of sex steroids, mediated a substantial proportion of the association.

Indexed as

AgedAlcohol DrinkingBreast NeoplasmsCase-Control StudiesEstradiolFemaleHumansIncidenceMiddle AgedPostmenopauseProspective StudiesSex Hormone-Binding GlobulinTestosteroneEstradiolSex Hormone-Binding GlobulinTestosteronealcoholbreast cancerEPIChormonal signaturemediation analysissex steroids

Identifiers

PMID30968961
PMCPMC6786903
OpenAlexW2937954440

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.